首页 > 市场调查报告书 > 製药

骨疾病

市场调查报告书

商品编码

1800895

2025 年至 2033 年骨关节炎治疗市场报告（依解剖类型、药物类型、给药途径、配销通路和地区）

Osteoarthritis Therapeutics Market Report by Anatomy Type, Drug Type, Route of Administration, Distribution Channel, and Region 2025-2033

出版日期: 2025年08月01日 | 出版商:

IMARC | 英文 141 Pages | 商品交期: 2-3个工作天内

价格

简介目录图表

2024 年全球骨关节炎治疗市场规模达 85 亿美元。展望未来， IMARC Group预计到 2033 年市场规模将达到 153 亿美元，2025-2033 年期间的成长率 (CAGR) 为 6.82%。

骨关节炎 (OA) 是一种异质性疾病，其特征是膝关节、髋关节、手关节、足关节、脊椎关节、肩关节和颈关节的软骨逐渐退化。 OA 通常会导致僵硬、肿胀、压痛、持续疼痛、灵活性丧失、摩擦感、骨刺和睡眠障碍。 OA 可以透过身体检查、X 光检查、关节镜检查、关节液分析、血液检查和磁振造影 (MRI) 扫描进行诊断。根据不同的检查结果，医生会开立各种药物和手术来缓解疾病的征兆和症状。目前，市面上有替代药物、物理治疗和支撑设备可用于缓解疼痛和改善关节功能。

全球骨关节炎治疗市场趋势与驱动因素：

久坐不动的生活方式、不健康的饮食习惯以及肥胖和高血糖盛行率的上升，正在增加人们罹患骨关节炎（OA）的风险。再加上老年人口的成长（老年人更容易患上此类疾病），这些因素共同构成了推动骨关节炎治疗市场成长的关键因素之一。此外，MRI扫描的便利获取也是另一个重要的成长诱因。此外，基于放射影像特征的影像生物标记的开发，加上镇痛药物的引入，也促进了市场的成长。此外，用于推出新型诊断方法和生物标记的研发投入不断增加，以及用于改善医疗基础设施的支出不断增加，也推动了市场的发展。例如，一些针对疾病修饰的药物正在开发中，这些药物专注于治疗软骨破坏的促发炎细胞因子。

本报告回答的关键问题

2024年全球骨关节炎治疗市场规模？ 2025年至2033年期间全球骨关节炎治疗市场的预期成长率为何？
推动全球骨关节炎治疗市场发展的关键因素有哪些？
COVID-19 对全球骨关节炎治疗市场有何影响？
根据解剖类型，全球骨关节炎治疗市场是如何分類的？
根据药物类型，全球骨关节炎治疗市场是如何分布的？
根据给药途径，全球骨关节炎治疗市场如何分布？
根据配销通路，全球骨关节炎治疗市场如何分布？
全球骨关节炎治疗市场的主要地区有哪些？
全球骨关节炎治疗市场的主要参与者/公司有哪些？

Osteoarthritis (OA) is a heterogeneous condition characterized by progressive degeneration of cartilage in joints of the knees, hips, hands, feet, spine, shoulders and neck. OA generally leads to stiffness, swelling, tenderness, persistent pain, loss of flexibility, grating sensation, bone spurs and sleep disturbances. It can be diagnosed using physical examination, X-ray, arthroscopy, joint fluid analysis, blood tests and magnetic resonance imaging (MRI) scan. Various medications and surgical procedures are prescribed as per the different results to alleviate the signs and symptoms of the disease. Currently, alternative medicines, physical therapies and supportive devices are available in the market to relieve pain and improve joint function.

Global Osteoarthritis Therapeutics Market Trends and Drivers:

Sedentary lifestyles, unhealthy dietary patterns and the rising prevalence of obesity and blood sugar are increasing the risk of developing OA among individuals. This, in confluence with the growing geriatric population, which is more susceptible to such ailments, represents one of the key factors impelling the osteoarthritis therapeutics market growth. Apart from this, the easy access to MRI scans is acting as another major growth-inducing factor. Additionally, the development of imaging biomarkers based on radiographic features, coupled with the introduction of analgesic drugs, is contributing to the market growth. Furthermore, rising investments in the research and development (R&D) activities to launch new diagnostics and biomarkers, along with the increasing expenditures on improving healthcare infrastructure, is also driving the market. For instance, disease-modifying drugs are under development, which focus on proinflammatory cytokines for treating cartilage breakdown.

Key Market Segmentation:

Breakup by Anatomy Type:

Knee
Hip
Hand
Spine
Others

Breakup by Drug Type:

Nonsteroidal Anti-Inflammatory Drugs
Analgesics
Corticosteroids
Others

Breakup by Route of Administration:

Parenteral
Topical
Oral

Breakup by Distribution Channel:

Hospitals
Specialty Clinics
Medical Institutions
Others

Breakup by Region:

North America
- United States
- Canada
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Latin America
- Brazil
- Mexico
- Others
Middle East and Africa

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Anika Therapeutics Inc., Bayer Aktiengesellschaft, Eli Lilly and Company, Flexion Therapeutics Inc., GlaxoSmithKline Plc, Horizon Therapeutics Plc, Johnson & Johnson Inc., Pfizer Inc. and Sanofi S.A.

Key Questions Answered in This Report

1.What was the size of the global osteoarthritis therapeutics market in 2024?
2.What is the expected growth rate of the global osteoarthritis therapeutics market during 2025-2033?
3.What are the key factors driving the global osteoarthritis therapeutics market?
4.What has been the impact of COVID-19 on the global osteoarthritis therapeutics market?
5.What is the breakup of the global osteoarthritis therapeutics market based on the anatomy type?
6.What is the breakup of the global osteoarthritis therapeutics market based on the drug type?
7.What is the breakup of the global osteoarthritis therapeutics market based on the route of administration?
8.What is the breakup of the global osteoarthritis therapeutics market based on the distribution channel?
9.What are the key regions in the global osteoarthritis therapeutics market?
10.Who are the key players/companies in the global osteoarthritis therapeutics market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Osteoarthritis Therapeutics Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Anatomy Type

6.1 Knee
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 Hip
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Hand
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
6.4 Spine
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
6.5 Others
- 6.5.1 Market Trends
- 6.5.2 Market Forecast

7 Market Breakup by Drug Type

7.1 Nonsteroidal Anti-Inflammatory Drugs
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Analgesics
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
7.3 Corticosteroids
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
7.4 Others
- 7.4.1 Market Trends
- 7.4.2 Market Forecast

8 Market Breakup by Route of Administration

8.1 Parenteral
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
8.2 Topical
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
8.3 Oral
- 8.3.1 Market Trends
- 8.3.2 Market Forecast

9 Market Breakup by Distribution Channel

9.1 Hospitals
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
9.2 Specialty Clinics
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
9.3 Medical Institutions
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
9.4 Others
- 9.4.1 Market Trends
- 9.4.2 Market Forecast

10 Market Breakup by Region

10.1 North America
- 10.1.1 United States
  - 10.1.1.1 Market Trends
  - 10.1.1.2 Market Forecast
- 10.1.2 Canada
  - 10.1.2.1 Market Trends
  - 10.1.2.2 Market Forecast
10.2 Asia Pacific
- 10.2.1 China
  - 10.2.1.1 Market Trends
  - 10.2.1.2 Market Forecast
- 10.2.2 Japan
  - 10.2.2.1 Market Trends
  - 10.2.2.2 Market Forecast
- 10.2.3 India
  - 10.2.3.1 Market Trends
  - 10.2.3.2 Market Forecast
- 10.2.4 South Korea
  - 10.2.4.1 Market Trends
  - 10.2.4.2 Market Forecast
- 10.2.5 Australia
  - 10.2.5.1 Market Trends
  - 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
  - 10.2.6.1 Market Trends
  - 10.2.6.2 Market Forecast
- 10.2.7 Others
  - 10.2.7.1 Market Trends
  - 10.2.7.2 Market Forecast
10.3 Europe
- 10.3.1 Germany
  - 10.3.1.1 Market Trends
  - 10.3.1.2 Market Forecast
- 10.3.2 France
  - 10.3.2.1 Market Trends
  - 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
  - 10.3.3.1 Market Trends
  - 10.3.3.2 Market Forecast
- 10.3.4 Italy
  - 10.3.4.1 Market Trends
  - 10.3.4.2 Market Forecast
- 10.3.5 Spain
  - 10.3.5.1 Market Trends
  - 10.3.5.2 Market Forecast
- 10.3.6 Russia
  - 10.3.6.1 Market Trends
  - 10.3.6.2 Market Forecast
- 10.3.7 Others
  - 10.3.7.1 Market Trends
  - 10.3.7.2 Market Forecast
10.4 Latin America
- 10.4.1 Brazil
  - 10.4.1.1 Market Trends
  - 10.4.1.2 Market Forecast
- 10.4.2 Mexico
  - 10.4.2.1 Market Trends
  - 10.4.2.2 Market Forecast
- 10.4.3 Others
  - 10.4.3.1 Market Trends
  - 10.4.3.2 Market Forecast
10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast

11 SWOT Analysis

11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
- 15.3.1 Abbott Laboratories
  - 15.3.1.1 Company Overview
  - 15.3.1.2 Product Portfolio
  - 15.3.1.3 Financials
  - 15.3.1.4 SWOT Analysis
- 15.3.2 Anika Therapeutics Inc.
  - 15.3.2.1 Company Overview
  - 15.3.2.2 Product Portfolio
  - 15.3.2.3 Financials
  - 15.3.2.4 SWOT Analysis
- 15.3.3 Bayer Aktiengesellschaft
  - 15.3.3.1 Company Overview
  - 15.3.3.2 Product Portfolio
  - 15.3.3.3 Financials
  - 15.3.3.4 SWOT Analysis
- 15.3.4 Eli Lilly and Company
  - 15.3.4.1 Company Overview
  - 15.3.4.2 Product Portfolio
  - 15.3.4.3 Financials
  - 15.3.4.4 SWOT Analysis
- 15.3.5 Flexion Therapeutics Inc.
  - 15.3.5.1 Company Overview
  - 15.3.5.2 Product Portfolio
  - 15.3.5.3 Financials
- 15.3.6 GlaxoSmithKline Plc
  - 15.3.6.1 Company Overview
  - 15.3.6.2 Product Portfolio
  - 15.3.6.3 Financials
  - 15.3.6.4 SWOT Analysis
- 15.3.7 Horizon Therapeutics Plc
  - 15.3.7.1 Company Overview
  - 15.3.7.2 Product Portfolio
  - 15.3.7.3 Financials
  - 15.3.7.4 SWOT Analysis
- 15.3.8 Johnson & Johnson Inc.
  - 15.3.8.1 Company Overview
  - 15.3.8.2 Product Portfolio
  - 15.3.8.3 Financials
  - 15.3.8.4 SWOT Analysis
- 15.3.9 Pfizer Inc.
  - 15.3.9.1 Company Overview
  - 15.3.9.2 Product Portfolio
  - 15.3.9.3 Financials
  - 15.3.9.4 SWOT Analysis
- 15.3.10 Sanofi S.A
  - 15.3.10.1 Company Overview
  - 15.3.10.2 Product Portfolio
  - 15.3.10.3 Financials
  - 15.3.10.4 SWOT Analysis

简介目录图表

List of Figures

Figure 1: Global: Osteoarthritis Therapeutics Market: Major Drivers and Challenges
Figure 2: Global: Osteoarthritis Therapeutics Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Osteoarthritis Therapeutics Market: Breakup by Anatomy Type (in %), 2024
Figure 4: Global: Osteoarthritis Therapeutics Market: Breakup by Drug Type (in %), 2024
Figure 5: Global: Osteoarthritis Therapeutics Market: Breakup by Route of Administration (in %), 2024
Figure 6: Global: Osteoarthritis Therapeutics Market: Breakup by Distribution Channel (in %), 2024
Figure 7: Global: Osteoarthritis Therapeutics Market: Breakup by Region (in %), 2024
Figure 8: Global: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 9: Global: Osteoarthritis Therapeutics (Knee) Market: Sales Value (in Million USD), 2019 & 2024
Figure 10: Global: Osteoarthritis Therapeutics (Knee) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 11: Global: Osteoarthritis Therapeutics (Hip) Market: Sales Value (in Million USD), 2019 & 2024

Figure 12 Global: Osteoarthritis Therapeutics (Hip) Market Forecast: Sales Value (in Million USD), 2025-2033

Figure 13: Global: Osteoarthritis Therapeutics (Hand) Market: Sales Value (in Million USD), 2019 & 2024
Figure 14: Global: Osteoarthritis Therapeutics (Hand) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 15: Global: Osteoarthritis Therapeutics (Spine) Market: Sales Value (in Million USD), 2019 & 2024
Figure 16: Global: Osteoarthritis Therapeutics (Spine) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 17: Global: Osteoarthritis Therapeutics (Other Anatomy Types) Market: Sales Value (in Million USD), 2019 & 2024
Figure 18: Global: Osteoarthritis Therapeutics (Other Anatomy Types) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 19: Global: Osteoarthritis Therapeutics (Nonsteroidal Anti-Inflammatory Drugs) Market: Sales Value (in Million USD), 2019 & 2024
Figure 20: Global: Osteoarthritis Therapeutics (Nonsteroidal Anti-Inflammatory Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 21: Global: Osteoarthritis Therapeutics (Analgesics) Market: Sales Value (in Million USD), 2019 & 2024
Figure 22: Global: Osteoarthritis Therapeutics (Analgesics) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 23: Global: Osteoarthritis Therapeutics (Corticosteroids) Market: Sales Value (in Million USD), 2019 & 2024
Figure 24: Global: Osteoarthritis Therapeutics (Corticosteroids) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 25: Global: Osteoarthritis Therapeutics (Other Drug Types) Market: Sales Value (in Million USD), 2019 & 2024
Figure 26: Global: Osteoarthritis Therapeutics (Other Drug Types) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 27: Global: Osteoarthritis Therapeutics (Parenteral) Market: Sales Value (in Million USD), 2019 & 2024
Figure 28: Global: Osteoarthritis Therapeutics (Parenteral) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 29: Global: Osteoarthritis Therapeutics (Topical) Market: Sales Value (in Million USD), 2019 & 2024
Figure 30: Global: Osteoarthritis Therapeutics (Topical) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 31: Global: Osteoarthritis Therapeutics (Oral) Market: Sales Value (in Million USD), 2019 & 2024
Figure 32: Global: Osteoarthritis Therapeutics (Oral) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 33: Global: Osteoarthritis Therapeutics (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
Figure 34: Global: Osteoarthritis Therapeutics (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 35: Global: Osteoarthritis Therapeutics (Specialty Clinics) Market: Sales Value (in Million USD), 2019 & 2024
Figure 36: Global: Osteoarthritis Therapeutics (Specialty Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 37: Global: Osteoarthritis Therapeutics (Medical Institutions) Market: Sales Value (in Million USD), 2019 & 2024
Figure 38: Global: Osteoarthritis Therapeutics (Medical Institutions) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 39: Global: Osteoarthritis Therapeutics (Other Distribution Channels) Market: Sales Value (in Million USD), 2019 & 2024
Figure 40: Global: Osteoarthritis Therapeutics (Other Distribution Channels) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 41: North America: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 42: North America: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 43: United States: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 44: United States: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 45: Canada: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 46: Canada: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 47: Asia Pacific: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 48: Asia Pacific: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 49: China: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 50: China: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 51: Japan: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 52: Japan: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 53: India: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 54: India: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 55: South Korea: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 56: South Korea: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 57: Australia: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 58: Australia: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 59: Indonesia: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 60: Indonesia: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 61: Others: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 62: Others: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 63: Europe: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 64: Europe: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 65: Germany: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 66: Germany: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 67: France: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 68: France: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 69: United Kingdom: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 70: United Kingdom: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 71: Italy: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 72: Italy: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 73: Spain: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 74: Spain: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 75: Russia: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 76: Russia: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 77: Others: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 78: Others: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 79: Latin America: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 80: Latin America: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 81: Brazil: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 82: Brazil: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 83: Mexico: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 84: Mexico: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 85: Others: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 86: Others: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 87: Middle East and Africa: Osteoarthritis Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 88: Middle East and Africa: Osteoarthritis Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 89: Global: Osteoarthritis Therapeutics Industry: SWOT Analysis
Figure 90: Global: Osteoarthritis Therapeutics Industry: Value Chain Analysis
Figure 91: Global: Osteoarthritis Therapeutics Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Osteoarthritis Therapeutics Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Osteoarthritis Therapeutics Market Forecast: Breakup by Anatomy Type (in Million USD), 2025-2033
Table 3: Global: Osteoarthritis Therapeutics Market Forecast: Breakup by Drug Type (in Million USD), 2025-2033
Table 4: Global: Osteoarthritis Therapeutics Market Forecast: Breakup by Route of Administration (in Million USD), 2025-2033
Table 5: Global: Osteoarthritis Therapeutics Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
Table 6: Global: Osteoarthritis Therapeutics Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 7: Global: Osteoarthritis Therapeutics Market: Competitive Structure
Table 8: Global: Osteoarthritis Therapeutics Market: Key Players

02-2729-4219

+886-2-2729-4219

License/价格

2025 年至 2033 年骨关节炎治疗市场报告（依解剖类型、药物类型、给药途径、配销通路和地区）

Osteoarthritis Therapeutics Market Report by Anatomy Type, Drug Type, Route of Administration, Distribution Channel, and Region 2025-2033

全球骨关节炎治疗市场趋势与驱动因素：

本报告回答的关键问题

目录

第一章：前言

第二章：范围与方法

第三章：执行摘要

第四章：简介

第五章：全球骨关节炎治疗市场

第六章：市场区隔：依结构类型

第七章：市场区隔：依药物类型

第八章：市场区隔：依行政途径

第九章：市场区隔：按配销通路

第十章：市场细分：按地区

第 11 章：SWOT 分析

第 12 章：价值链分析

第 13 章：波特五力分析

第 14 章：价格分析

第 15 章：竞争格局